Search Page

1

Cite

Share

Type 2 diabetes.

Chatterjee S, Khunti K, Davies MJ. Chatterjee S, et al. Among authors: davies mj. Lancet. 2017 Jun 3;389(10085):2239-2251. doi: 10.1016/S0140-6736(17)30058-2. Epub 2017 Feb 10. Lancet. 2017. PMID: 28190580 Review.

Cite

Share

2

Cite

Share

Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention.

Selvarajah D, Kar D, Khunti K, Davies MJ, Scott AR, Walker J, Tesfaye S. Selvarajah D, et al. Among authors: davies mj. Lancet Diabetes Endocrinol. 2019 Dec;7(12):938-948. doi: 10.1016/S2213-8587(19)30081-6. Epub 2019 Oct 14. Lancet Diabetes Endocrinol. 2019. PMID: 31624024 Free article. Review.

Cite

Share

3

Cite

Share

Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective.

Zaccardi F, Webb DR, Yates T, Davies MJ. Zaccardi F, et al. Among authors: davies mj. Postgrad Med J. 2016 Feb;92(1084):63-9. doi: 10.1136/postgradmedj-2015-133281. Epub 2015 Nov 30. Postgrad Med J. 2016. PMID: 26621825 Review.

Cite

Share

4

Cite

Share

2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Buse JB, Wexler DJ, Tsapas A, Rossing P, Mingrone G, Mathieu C, D'Alessio DA, Davies MJ. Buse JB, et al. Among authors: davies mj. Diabetes Care. 2020 Feb;43(2):487-493. doi: 10.2337/dci19-0066. Epub 2019 Dec 19. Diabetes Care. 2020. PMID: 31857443 Free PMC article.

Cite

Share

5

Cite

Share

Diabetes structured self-management education programmes: a narrative review and current innovations.

Chatterjee S, Davies MJ, Heller S, Speight J, Snoek FJ, Khunti K. Chatterjee S, et al. Among authors: davies mj. Lancet Diabetes Endocrinol. 2018 Feb;6(2):130-142. doi: 10.1016/S2213-8587(17)30239-5. Epub 2017 Sep 29. Lancet Diabetes Endocrinol. 2018. PMID: 28970034 Review.

Cite

Share

6

Cite

Share

The effects of high-intensity interval training on glucose regulation and insulin resistance: a meta-analysis.

Jelleyman C, Yates T, O'Donovan G, Gray LJ, King JA, Khunti K, Davies MJ. Jelleyman C, et al. Among authors: davies mj. Obes Rev. 2015 Nov;16(11):942-61. doi: 10.1111/obr.12317. Obes Rev. 2015. PMID: 26481101 Review.

Cite

Share

7

Cite

Share

Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis.

Htike ZZ, Zaccardi F, Papamargaritis D, Webb DR, Khunti K, Davies MJ. Htike ZZ, et al. Among authors: davies mj. Diabetes Obes Metab. 2017 Apr;19(4):524-536. doi: 10.1111/dom.12849. Epub 2017 Feb 17. Diabetes Obes Metab. 2017. PMID: 27981757 Review.

Cite

Share

8

Cite

Share

Guideline recommendations and the positioning of newer drugs in type 2 diabetes care.

Marx N, Davies MJ, Grant PJ, Mathieu C, Petrie JR, Cosentino F, Buse JB. Marx N, et al. Among authors: davies mj. Lancet Diabetes Endocrinol. 2021 Jan;9(1):46-52. doi: 10.1016/S2213-8587(20)30343-0. Epub 2020 Nov 4. Lancet Diabetes Endocrinol. 2021. PMID: 33159841 Review.

Cite

Share

9

Cite

Share

Detection, identification, and quantification of oxidative protein modifications.

Hawkins CL, Davies MJ. Hawkins CL, et al. Among authors: davies mj. J Biol Chem. 2019 Dec 20;294(51):19683-19708. doi: 10.1074/jbc.REV119.006217. Epub 2019 Oct 31. J Biol Chem. 2019. PMID: 31672919 Free PMC article. Review.

Cite

Share

10

Cite

Share

The right place for Sulphonylureas today.

Webb DR, Davies MJ, Jarvis J, Seidu S, Khunti K. Webb DR, et al. Among authors: davies mj. Diabetes Res Clin Pract. 2019 Nov;157:107836. doi: 10.1016/j.diabres.2019.107836. Epub 2019 Aug 31. Diabetes Res Clin Pract. 2019. PMID: 31479704 Review.

Cite

Share